病原和可能的治疗方法之间的关系 MASLD - 肝硬化谱的治疗方法
Paulina Vidal-Cevallos1, Adriana P Sorroza-Martínez2, Norberto C Chávez-Tapia1,2
1Obesity and Digestive Diseases Unit, Medica Sur Clinic & Foundation, Mexico City 14050, Mexico.
International journal of molecular sciences
|April 27, 2024
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 涉及由于代谢问题而导致肝脏脂肪的积累. 改变生活方式是关键,但有些患者可能需要药物治疗MASLD.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
- 胃肠病学 胃肠病学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 涵盖了一系列肝脏疾病.
- MASLD的发展是多因素的,受环境,微生物群,并发症和遗传学的影响.
- 它与代谢综合征有关,其特点是由于脂肪酸代谢失衡而导致肝脏脂质积累.
研究的目的:
- 审查影响MASLD发展和进展的因素.
- 讨论 MASLD 导致纤维化的机制.
- 突出目前和潜在的治疗策略,为MASLD.
主要方法:
- 关于MASLD病原和治疗的文献综述.
- 对代谢综合征和生活方式在MASLD中的作用的分析.
- 检查从肥胖症到纤维化的进展.
主要成果:
- MASLD向纤维化进展涉及线粒体脂肪酸过载,氧化应激和脂质过氧化.
- 不健康的生活习惯和表观遗传/遗传因素有助于MASLD的发展.
- 显著的体重减轻 (≥10%) 可以解决脂肪肝炎和回归纤维化.
结论:
- 改变生活方式是MASLD和非酒精性脂肪肝炎的主要治疗方法.
- 药理干预对于无法减肥的特定患者群体是必要的.
- 对MASLD机制和治疗方法的进一步研究是有必要的.
相关概念视频
Diseases of the Liver and Gallbladder
531
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
531
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Chronic Bowel Disorders: Introduction
446
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
446
Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
160
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
160
Pleural Effusion II: Symptoms and Management
165
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
165


